In 2024, Marc N. Casper earned $7.78M in total compensation at Thermo Fisher Scientific, including $1.74M salary and $5.51M bonus. Most recently sold 54,000 shares in Mar 2025. Currently holds stock worth $77.08M. Has donated $128.77M in stock to charitable causes. Has led Thermo Fisher Scientific for over 16 years.
Compensation History
Annual executive compensation data for Marc N. Casper, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$7.78M
Salary
$1.74M
Bonus
$5.51M
Other
$537.49K
Salary
$1.74MBoard Justification
We believe the most effective way to achieve these objectives is to reference the market median for target direct compensation, with adjustment for performance and experience, and to offer performance-based incentives tied to clearly articulated performance measures aligned to our key strategic and financial goals that reward our executives for over-performance and hold them accountable for under-performance.
Bonus
$5.51MBoard Justification
The final award can range from 0% to 200% of target, depending on the financial and non-financial performance of the Company against pre-set performance targets.
Other Compensation
$537.49KBoard Justification
Includes matching contributions made on behalf of the NEOs by the Company pursuant to the Company’s 401(k) plan, premiums paid by the Company with respect to long-term disability insurance for the benefit of the NEOs, matching contributions made on behalf of the NEOs by the Company pursuant to the Company’s non-qualified deferred compensation plan, dividends accrued in the form of dividend equivalents on restricted stock units, excluding the impact to the number of performance-based restricted stock units based on relative TSR performance, financial planning services, premiums paid by the Company with respect to executive group term life insurance, access to executive physicals, and with respect to Mr. Casper, premiums paid by the Company for a term life insurance policy for the benefit of Mr. Casper, personal security services, and the incremental cost to the Company of his non-business use of Company aircraft as authorized by the Compensation Committee, which has determined that such aircraft usage increases the security, availability, and productivity of the CEO, providing substantial benefits that justify the cost.
Restricted Stock
Board Justification
N/A
Performance Metrics
Organic revenue growth, adjusted net income, free cash flow, adjusted earnings per share, and continued focus on relative total shareholder return.
Marc N. Casper
CEO of Thermo Fisher Scientific
Education
Bachelor's degree in Biology from the University of California, San Diego
Field of Expertise
Healthcare & Life Sciences - Life Sciences
Sector of Economy
Healthcare
Born
August 1, 1965 - 60 years ago
CEO of Thermo Fisher Scientific for
16 years 1 month (Oct 2009 - Present)
Previous Experience
Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific
Other Thermo Fisher Scientific CEOs
Holdings
Track Marc N. Casper's stock holdings and portfolio value over time.
Total Stock Sold
$724.06M
$724.06M
2,534,888 TMO shares
What if they kept their stock?
If Marc N. Casper didn't sell their stock, today they would have:
Extra TMO2,534,888 shares worth $1.46B.
This is 101.39% and $734.11M more than what they got when they sold the stock.
Charitable Transactions
223,855 shares
TMO
Recent Charitable Transactions
2,750 shares
TMO
Feb 14, 2025
Charity
2,000 shares
TMO
Mar 11, 2024
Charity
6,000 shares
TMO
Nov 29, 2023
Charity
9,300 shares
TMO
Aug 3, 2023
Charity
9,300 shares
TMO
Feb 9, 2023
Charity
5,000 shares
TMO
May 2, 2022
Charity
Insider Trading
Marc N. Casper's recent stock transactions, purchases, and sales filed with the SEC.
$28.02M
TMO at $518.81/share
Mar 4, 2025
Sale
23,736 shares
TMO
Feb 19, 2025
Received
2,750 shares
TMO
Feb 14, 2025
Charity
$10.63M
TMO at $531.45/share
Dec 2, 2024
Sale
$4.98M
TMO at $552.95/share
Nov 8, 2024
Sale
$11.17M
TMO at $558.28/share
Nov 6, 2024
Sale
$3.25M
TMO at $556.37/share
Nov 1, 2024
Sale
$11.00M
TMO at $549.86/share
Oct 30, 2024
Sale
$11.06M
TMO at $553.11/share
Oct 28, 2024
Sale
$12.19M
TMO at $609.32/share
Sep 3, 2024
Sale
Rivals
Compare Marc N. Casper with competitor CEOs and industry peers.
Brian S. Tyler
CEO of McKesson
2023 Compensation
Stock
$53.90M
Salary
$1.49M
Bonus
$0.00
Other
$864.73K
Total Holdings
$230.10K
August J. Troendle
Founder and CEO of Medpace Holdings, Inc.
2023 Compensation
Stock
$0.00
Salary
$825.00K
Bonus
$814.42K
Other
$17.33K
Total Holdings
$513.58M
Eric M. Green
CEO of West Pharmaceutical Services
2023 Compensation
Stock
$0.00
Salary
$1.14M
Bonus
$1.67M
Other
$92.48K
Total Holdings
$159.06M
Thomas P. Joyce, Jr.
CEO of Danaher
2024 Compensation
Stock
$5.02M
Salary
$1.35M
Bonus
$0.00
Other
$506.42K
Total Holdings
$1.66M